Cormack Scott Daniel - Insider Stock Trading

TC	Stat	Stk	Ins	Fil	+d	+w	+m	+q	+h	+y	avg
P	%ret	1	1	1	0	3	-14	16	17	858	176
P	%wins				100	100	0	100	100	100	83
S	%ret	1	1	12	-1	-0	-4	-8	-18	-46	-13
S	%wins				92	75	75	67	67	100	79

Filing Date	T Date	Ticker	Issuer	Inc	Sector	Ind	Industry	Owner	oSt	Rel	Title	T	TVal	Price	L	Qty	oc	Own	H	r2y	r1y	r6m	r3m	r6w	r3w	r7d	r3d	f1d	f1w	f1m	f3m	f6m	f1y
8/3/17 20:58	8/1/17	ACHV	Achieve Life Sciences, Inc.	DE	Health	Diagn	In Vitro & In Vivo Diagnostic	Cormack Scott Daniel	WA	D		M.d	0	0.00	0	5	22	26	M
6/14/17 16:39	6/12/17	OGXI	Oncogenex Pharmaceuticals, Inc.	DE	Health	Diagn	In Vitro & In Vivo Diagnostic	Cormack Scott Daniel	A1	DO	P,CEO	M.d	0	0.00	0	14	7	234	M
1/12/17 11:31	1/10/17	OGXI	Oncogenex Pharmaceuticals, Inc.	DE	Health	Diagn	In Vitro & In Vivo Diagnostic	Cormack Scott Daniel	A1	DO	P,CEO	M.d	0	0.00	1	31	16	224	M	-74	-28	-40	37	16	28	18	-16	8	-5	-2	-27
6/15/16 17:50	6/13/16	OGXI	Oncogenex Pharmaceuticals, Inc.	DE	Health	Diagn	In Vitro & In Vivo Diagnostic	Cormack Scott Daniel	A1	DO	P,CEO	M.d	0	0.00	1	14	8	203	M	-68	-61	-8	30	6	11	-10	7	-3	-3	-9	-49	-50
6/15/16 17:50	6/13/16	OGXI	Oncogenex Pharmaceuticals, Inc.	DE	Health	Diagn	In Vitro & In Vivo Diagnostic	Cormack Scott Daniel	A1	DO	P,CEO	S.d	-5	1.03	1	-5	-2	203	M	-68	-61	-8	30	6	11	-10	7	-3	-3	-9	-49	-50
3/16/16 18:26	3/14/16	OGXI	Oncogenex Pharmaceuticals, Inc.	DE	Health	Diagn	In Vitro & In Vivo Diagnostic	Cormack Scott Daniel	A1	DO	P,CEO	M.d	0	0.00	0	25	15	194	D	-93	-64	-67	-29	34	32	11	6	-4	-6	1	31	-36	-38
3/16/16 18:26	3/15/16	OGXI	Oncogenex Pharmaceuticals, Inc.	DE	Health	Diagn	In Vitro & In Vivo Diagnostic	Cormack Scott Daniel	A1	DO	P,CEO	S.d	-10	0.8300	0	-12	-6	194	D	-93	-64	-67	-29	34	32	11	6	-4	-6	1	31	-36	-38
6/16/15 15:06	6/12/15	OGXI	Oncogenex Pharmaceuticals, Inc.	DE	Health	Diagn	In Vitro & In Vivo Diagnostic	Cormack Scott Daniel	A1	DO	P,CEO	M.d	0	0.00	2	9	9	112	D	-72	-18	18	19	38	28	10	-1	-3	1	-10	-9	-58	-61
6/16/15 15:06	6/12/15	OGXI	Oncogenex Pharmaceuticals, Inc.	DE	Health	Diagn	In Vitro & In Vivo Diagnostic	Cormack Scott Daniel	A1	DO	P,CEO	S.d	-12	2.69	2	-5	-4	112	D	-72	-18	18	19	38	28	10	-1	-3	1	-10	-9	-58	-61
5/21/15 18:28	5/19/15	OGXI	Oncogenex Pharmaceuticals, Inc.	DE	Health	Diagn	In Vitro & In Vivo Diagnostic	Cormack Scott Daniel	A1	DO	P,CEO	M.d	0	0.00	0	16	17	107	D	-82	-50	-14	-16	-18	-6	6	-3	-2	14	45	48	24	-52
5/21/15 18:28	5/20/15	OGXI	Oncogenex Pharmaceuticals, Inc.	DE	Health	Diagn	In Vitro & In Vivo Diagnostic	Cormack Scott Daniel	A1	DO	P,CEO	S.d	-14	1.88	0	-8	-7	107	D	-82	-50	-14	-16	-18	-6	6	-3	-2	14	45	48	24	-52
1/30/15 18:46	1/27/15	OGXI	Oncogenex Pharmaceuticals, Inc.	DE	Health	Diagn	In Vitro & In Vivo Diagnostic	Cormack Scott Daniel	A1	DO	P,CEO	M.d	0	0.00	1	20	25	99	D	-85	-80	-34	-8	-10	-12	-11	-4	2	-1	20	0	61	-67
9/19/14 15:31	9/17/14	OGXI	Oncogenex Pharmaceuticals, Inc.	DE	Health	Diagn	In Vitro & In Vivo Diagnostic	Cormack Scott Daniel	A1	DO	P,CEO	M.d	0	0.00	1	7	9	88	D	-79	-68	-76	-15	-5	-9	-5	-2	-7	-8	-27	-26	-23	-3
8/14/14 18:01	8/12/14	OGXI	Oncogenex Pharmaceuticals, Inc.	DE	Health	Diagn	In Vitro & In Vivo Diagnostic	Cormack Scott Daniel	A1	DO	P,CEO	M.d	0	0.00	0	38	80	84	D	-77	-65	-72	-17	-9	3	12	5	0	-3	-5	-35	-36	-4
8/14/14 18:01	8/13/14	OGXI	Oncogenex Pharmaceuticals, Inc.	DE	Health	Diagn	In Vitro & In Vivo Diagnostic	Cormack Scott Daniel	A1	DO	P,CEO	S.d	-58	3.17	0	-18	-18	84	D	-77	-65	-72	-17	-9	3	12	5	0	-3	-5	-35	-36	-4
3/18/14 19:22	3/14/14	OGXI	Oncogenex Pharmaceuticals, Inc.	DE	Health	Diagn	In Vitro & In Vivo Diagnostic	Cormack Scott Daniel	A1	DO	P,CEO	M.d	0	0.00	4	9	8	122	D	-21	1	35	53	16	9	0	-5	-1	-1	-23	-76	-80	-86
3/18/14 19:22	3/17/14	OGXI	Oncogenex Pharmaceuticals, Inc.	DE	Health	Diagn	In Vitro & In Vivo Diagnostic	Cormack Scott Daniel	A1	DO	P,CEO	S.d	-57	12.25	4	-5	-4	122	D	-21	1	35	53	16	9	0	-5	-1	-1	-23	-76	-80	-86
10/7/13 15:21	8/19/13	OGXI	Oncogenex Pharmaceuticals, Inc.	DE	Health	Diagn	In Vitro & In Vivo Diagnostic	Cormack Scott Daniel	A1	DO	P,CEO	S.a	-27	8.68	1	-3	-5	60	D	-2	-38	-14	-8	-3	-3	-1	-2	-1	-1	-22	3	10	-73
10/7/13 15:19	3/12/13	OGXI	Oncogenex Pharmaceuticals, Inc.	DE	Health	Diagn	In Vitro & In Vivo Diagnostic	Cormack Scott Daniel	A1	DO	P,CEO	S.a	-25	11.90	1	-2	-4	57	D	-2	-38	-14	-8	-3	-3	-1	-2	-1	-1	-22	3	10	-73
8/15/13 18:06	8/13/13	OGXI	Oncogenex Pharmaceuticals, Inc.	DE	Health	Diagn	In Vitro & In Vivo Diagnostic	Cormack Scott Daniel	A1	DO	P,CEO	M.d	0	0.00	1	7	6	118	D	-21	-36	-23	-9	-1	-8	-5	-1	0	-1	3	-19	31	-61
3/14/13 17:04	3/12/13	OGXI	Oncogenex Pharmaceuticals, Inc.	DE	Health	Diagn	In Vitro & In Vivo Diagnostic	Cormack Scott Daniel	A1	DO	P,CEO	M.d	0	0.00	1	5	4	114	D	-21	-23	-12	-6	-9	0	-3	-1	0	-4	-14	-19	-25	1
8/7/12 13:57	8/7/12	OGXI	Oncogenex Pharmaceuticals, Inc.	DE	Health	Diagn	In Vitro & In Vivo Diagnostic	Cormack Scott Daniel	A1	DO	P,CEO	M.d	29	4.11	1	7	7	112	D	-3	25	-4	12	7	-1	2	3	-1	-2	-5	-15	-16	-34
8/1/12 18:03	7/30/12	OGXI	Oncogenex Pharmaceuticals, Inc.	DE	Health	Diagn	In Vitro & In Vivo Diagnostic	Cormack Scott Daniel	A1	DO	P,CEO	M.d	140	4.11	0	34	48	105	D	-5	-1	0	7	4	-2	-3	-1	-2	2	2	-11	-8	-29
8/8/11 14:30	8/5/11	OGXI	Oncogenex Pharmaceuticals, Inc.	DE	Health	Diagn	In Vitro & In Vivo Diagnostic	Cormack Scott Daniel	A1	DO	P,CEO	M.d	21	4.11	1	5	8	70	M	-60	-23	-29	-26	-34	-27	-20	-15	-11	-1	-8	1	31	25
1/6/11 19:05	1/4/11	OGXI	Oncogenex Pharmaceuticals, Inc.	DE	Health	Diagn	In Vitro & In Vivo Diagnostic	Cormack Scott Daniel	A1	DO	P,CEO	M.dm	73	3.89	1	19	40	65	M	286	-21	31	19	5	7	7	2	-1	0	-7	-10	0	-34
1/6/11 19:05	1/4/11	OGXI	Oncogenex Pharmaceuticals, Inc.	DE	Health	Diagn	In Vitro & In Vivo Diagnostic	Cormack Scott Daniel	A1	DO	P,CEO	S.d	-165	16.52	1	-10	-13	65	M	286	-21	31	19	5	7	7	2	-1	0	-7	-10	0	-34
12/10/10 12:11	12/8/10	OGXI	Oncogenex Pharmaceuticals, Inc.	DE	Health	Diagn	In Vitro & In Vivo Diagnostic	Cormack Scott Daniel	A1	DO	P,CEO	M.d	99	9.92	1	10	21	57	I	163	-50	12	27	-1	-3	0	-1	0	0	6	-6	16	-33
12/3/10 16:52	12/1/10	OGXI	Oncogenex Pharmaceuticals, Inc.	DE	Health	Diagn	In Vitro & In Vivo Diagnostic	Cormack Scott Daniel	A1	DO	P,CEO	M.dm	39	3.89	1	10	21	57	M	611	-52	12	23	-8	0	-4	-1	0	0	5	-3	13	-28
12/3/10 16:52	12/1/10	OGXI	Oncogenex Pharmaceuticals, Inc.	DE	Health	Diagn	In Vitro & In Vivo Diagnostic	Cormack Scott Daniel	A1	DO	P,CEO	S.d	-80	16.02	1	-5	-8	57	M	611	-52	12	23	-8	0	-4	-1	0	0	5	-3	13	-28
11/17/10 16:19	11/15/10	OGXI	Oncogenex Pharmaceuticals, Inc.	DE	Health	Diagn	In Vitro & In Vivo Diagnostic	Cormack Scott Daniel	A1	DO	P,CEO	M.dm	39	3.89	2	10	24	52	M	563	-49	-7	15	11	-5	0	-1	3	2	0	-1	-3	-23
11/17/10 16:19	11/15/10	OGXI	Oncogenex Pharmaceuticals, Inc.	DE	Health	Diagn	In Vitro & In Vivo Diagnostic	Cormack Scott Daniel	A1	DO	P,CEO	S.d	-80	15.99	2	-5	-9	52	M	563	-49	-7	15	11	-5	0	-1	3	2	0	-1	-3	-23
11/2/10 18:58	11/1/10	OGXI	Oncogenex Pharmaceuticals, Inc.	DE	Health	Diagn	In Vitro & In Vivo Diagnostic	Cormack Scott Daniel	A1	DO	P,CEO	M.d	39	3.89	3	10	27	47	D	513	-45	-27	6	30	-14	-9	-5	-1	-3	-2	-3	-5	-30
11/2/10 18:58	11/1/10	OGXI	Oncogenex Pharmaceuticals, Inc.	DE	Health	Diagn	In Vitro & In Vivo Diagnostic	Cormack Scott Daniel	A1	DO	P,CEO	S.d	-77	15.45	3	-5	-10	47	D	513	-45	-27	6	30	-14	-9	-5	-1	-3	-2	-3	-5	-30
8/27/10 13:49	8/25/10	OGXI	Oncogenex Pharmaceuticals, Inc.	DE	Health	Diagn	In Vitro & In Vivo Diagnostic	Cormack Scott Daniel	A1	O	P,CEO	M.d	7	3.89	0	2	4	42	D	89	-62	-25	-18	1	-16	-10	-5	4	4	5	31	26	-13
1/29/10 11:04	1/28/10	OGXI	Oncogenex Pharmaceuticals, Inc.	DE	Health	Diagn	In Vitro & In Vivo Diagnostic	Cormack Scott Daniel	A1	DO	P,CEO	M.d	28	3.89	4	7	21	40	I	101	167	-51	-55	-53	-34	-21	-8	0	5	20	52	0	13
7/10/09 16:28	7/10/09	OGXI	Oncogenex Pharmaceuticals, Inc.	DE	Health	Diagn	In Vitro & In Vivo Diagnostic	Cormack Scott Daniel	A1	DO	P,CEO	M.d	3	3.89	5	1	3	33	B									0	6	46	79	5	-36
12/29/08 10:20	12/23/08	OGXI	Oncogenex Pharmaceuticals, Inc.	DE	Health	Diagn	In Vitro & In Vivo Diagnostic	Cormack Scott Daniel	A1	DO	P,CEO	M.d	97	3.89	1	25	339	32	M	-96	-45	-14	7	70	-43	-26	3	-23	3	27	1	445	438
9/29/08 16:32	9/26/08	OGXI	Oncogenex Pharmaceuticals, Inc.	DE	Health	Diagn	In Vitro & In Vivo Diagnostic	Cormack Scott Daniel	A1	DO	P,CEO	P	20	3.99	0	5	383	6	D	-95	-65	-40	-20	-14	-34	-12	-5	0	3	-14	16	17	858

D	Derivative transaction in filing (usually option exercise)
M	Multiple transactions in filing; earliest reported transaction date and weighted average transaction price
A	Amended filing
E	Error detected in filing

S - Sale	Sale of securities on an exchange or to another person
S - Sale+OE	Sale of securities on an exchange or to another person (after option exercise)
F - Tax	Payment of exercise price or tax liability using portion of securities received from the company
P - Purchase	Purchase of securities on an exchange or from another person

TC

Stat

Stk

Ins

Fil

+d

+w

+m

+q

+h

+y

avg

Filing Date

T Date

Ticker

Issuer

Inc

Sector

Ind

Industry

Owner

oSt

Rel

Title

T

TVal

Price

L

Qty

oc

Own

H

r2y

r1y

r6m

r3m

r6w

r3w

r7d

r3d

f1d

f1w

f1m

f3m

f6m

f1y